Judith Ann Hemberger
Chief Executive Officer at SuviCa, Inc.
Profile
Judith Ann Hemberger was the founder of Pharmion Corp.
(founded in 2000) where she held the title of Chief Operating Officer & EVP.
She is currently the Chairman & Chief Executive Officer at SuviCa, Inc. and a Director at the Parkinson's Institute & Clinical Center.
In her former positions, Dr. Hemberger served as Chairman at Clarimedix, Inc., Director at Perrigo Co., NeXstar Pharmaceuticals, Inc., Cell Pathways, Inc., Renovis, Inc., VasoGenix Pharmaceuticals, Inc., Gilead Colorado, Inc., Novacea, Inc., Chroma Therapeutics Ltd., HealthShares, Inc., The Schein Group, Inc., Algeta ASA, Atani Ltd., and Phase4 Partners Ltd.
She was also the SVP-Business Development at AVAX Technologies, Inc. from 1997 to 1999 and held the title of Partner at Phase4 Partners Ltd.
in 2009.
Additionally, she served as SVP-Global Drug Regulatory Affairs at Marion Merrell Dow, Inc. and Hoechst Marion Roussel, Inc.Dr. Hemberger obtained an MBA from Rockhurst University, a doctorate from the University of Missouri, and an undergraduate degree from Benedictine College.
Judith Ann Hemberger active positions
| Companies | Position | Start |
|---|---|---|
SuviCa, Inc.
 SuviCa, Inc. Miscellaneous Commercial ServicesCommercial Services SuviCa, Inc. is an American biotechnology company that operates in an unspecified location. The CEO of the private company is Judith Ann Hemberger. | Chief Executive Officer | - |
Parkinson's Institute & Clinical Center
 Parkinson's Institute & Clinical Center Medical/Nursing ServicesHealth Services Parkinson''s Institute & Clinical Center provides patient care. It offers clinical trials, physical therapy, and speech therapy. The company was founded by J. William Langston in 1988 and is headquartered in Sunnyvale, CA | Director/Board Member | - |
Former positions of Judith Ann Hemberger
| Companies | Position | End |
|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Director/Board Member | 2009-10-27 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Director/Board Member | 2009-02-02 |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Corporate Officer/Principal | 2008-12-31 |
| PRA HEALTH SCIENCES, INC. | Director/Board Member | 2007-12-12 |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Director/Board Member | 2006-11-16 |
Training of Judith Ann Hemberger
| Rockhurst University | Masters Business Admin |
| University of Missouri | Doctorate Degree |
| Benedictine College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| Private companies | 22 |
|---|---|
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI. | Health Technology |
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | Health Technology |
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights, and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. | Commercial Services |
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
VasoGenix Pharmaceuticals, Inc.
 VasoGenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vasogenix Pharmaceuticals, Inc. develops cardiology drug products for acute treatment of life threatening ischemia associated with myocardial infarction and the chronic treatment of congestive heart failure. The company was founded in 2001 and is headquartered in Lenexa, KS. | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Finance |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
Clarimedix, Inc.
 Clarimedix, Inc. Medical SpecialtiesHealth Technology Clarimedix, Inc. develops pipeline products for diseases associated with vascular dysfunction. It offers products for the treatment of cerebral vasospasm, raynaud’s syndrome and alzheimer’s disease. Clarimedix was founded in 2006 and was headquartered in Aurora, CO. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Health Technology |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
| HealthShares, Inc. | Miscellaneous |
| The Schein Group, Inc. | |
| Hoechst Marion Roussel, Inc. | |
Atani Ltd.
 Atani Ltd. Pharmaceuticals: GenericHealth Technology Atani Ltd. manufactures and markets drugs. The firm's drugs are used for the treatment of cancer. The company was founded by Stefan Wohlfeil and is headquartered in Tokyo, Japan | Health Technology |
Parkinson's Institute & Clinical Center
Parkinson's Institute & Clinical Center Medical/Nursing ServicesHealth Services Parkinson''s Institute & Clinical Center provides patient care. It offers clinical trials, physical therapy, and speech therapy. The company was founded by J. William Langston in 1988 and is headquartered in Sunnyvale, CA | Health Services |
SuviCa, Inc.
SuviCa, Inc. Miscellaneous Commercial ServicesCommercial Services SuviCa, Inc. is an American biotechnology company that operates in an unspecified location. The CEO of the private company is Judith Ann Hemberger. | Commercial Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Judith Ann Hemberger
